Informex – companies hope for a brighter 2010

By Nick Taylor

- Last updated on GMT

Related tags Management Economics India China

Informex – companies hope for a brighter 2010
There are signs that 2010 will be a better year for the fine and custom chemistry industry but companies at Informex remained cautious and are planning accordingly.

Business from biotechs remains down and large pharma’s focus on cost cutting is squeezing suppliers but overall the industry is healthier than it was 12 months ago.

This has led companies to adopt a reservedly optimistic outlook for the year ahead. Whatever the financial situation, the establishment of strong working relationships and provision of quality, on time services continue to be vital for growing business.

India, China and other emerging markets are making gains in this area but still have work to do.

Related news

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Addressing Challenges with Clinical In-Use Testing

Addressing Challenges with Clinical In-Use Testing

Content provided by Lonza | 12-Oct-2023 | White Paper

Lonza Drug Product expert Léa Sorret PhD explores Clinical In-Use Testing of Biotherapeutics in this white paper. Léa shares her expertise and describes...

PBPK modeling that saves you time and money

PBPK modeling that saves you time and money

Content provided by Lonza Small Molecules | 09-Oct-2023 | White Paper

Understanding pharmacokinetic behaviors ahead of later-stage development means making informed decisions earlier. This enhanced capability helps your drug...

Related suppliers

Follow us

Products

View more

Webinars